This is a story from our 2017/18 annual report. Read more stories from the annual report here.

Using Vivametrica’s software, data from smartphone and wearable devices can now predict the likelihood of chronic disease and generate personalized health analytics and health scores. With these digital tools, insurers can evaluate risk without the process of medical exams, fluid draws, or lengthy questionnaires, making Vivametrica’s analysis faster, lower cost and more convenient. Through the Creative Destruction Lab (CDL) Rockies (seed-stage program for massively scalable, science-based companies), the company successfully raised a $750,000 investment round.

Learn more and apply: